CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 99 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,832,000 | +151.7% | 341,584 | +105.5% | 0.00% | 0.0% |
Q4 2021 | $1,125,000 | +26.0% | 166,223 | -1.3% | 0.00% | 0.0% |
Q3 2021 | $893,000 | -6.3% | 168,398 | +1.6% | 0.00% | 0.0% |
Q2 2021 | $953,000 | -0.2% | 165,722 | -20.0% | 0.00% | 0.0% |
Q1 2021 | $955,000 | +139.3% | 207,255 | +73.4% | 0.00% | – |
Q4 2020 | $399,000 | +14.7% | 119,529 | +2.0% | 0.00% | – |
Q3 2020 | $348,000 | -14.1% | 117,185 | +33.6% | 0.00% | – |
Q2 2020 | $405,000 | +113.2% | 87,698 | +77.7% | 0.00% | – |
Q1 2020 | $190,000 | -18.5% | 49,353 | -20.4% | 0.00% | – |
Q4 2019 | $233,000 | +247.8% | 62,008 | +392.9% | 0.00% | – |
Q3 2019 | $67,000 | -93.0% | 12,579 | -93.3% | 0.00% | -100.0% |
Q1 2019 | $952,000 | -6.8% | 186,708 | -28.6% | 0.00% | 0.0% |
Q4 2017 | $1,022,000 | – | 261,325 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |